News > AASLD. Industry Colloquium: Novel Targets and Therapies in Liver Disease

Events

AASLD. Industry Colloquium: Novel Targets and Therapies in Liver Disease

 

Organized by American Association for the Study of Liver Diseases (AASLD)

 

This Industry Colloquium will provide a unique and rare opportunity for interactions between Industry and liver disease experts. Seeking to help identify unmet needs in hepatology, this one and one-half day conference will look toward the future to determine how to address the long-term challenges that hepatologists are likely to face in the coming years.

 

When: March 20, 2015 - March 21, 2015

 

Where: Hilton Durham Research Triangle Park, North Carolina

 

Attendee from OWL: Dr. Pablo Ortiz 

 

We invite you to know more about OWLiver Care, the non-invasive test for screening fatty liver, and visit  the poster “INCIDENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NON-OBESE AND NON-DIABETIC INDIVIDUALS DURING NORMAL AGING” (Poster #: 11)

Download file

http://www.aasld.org/events-professional-development/industry-colloquium

OWL is a trading name of
ONE WAY LIVER, S.L
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
Phone:
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 11/29/2021

With the collaboration of: